AI in Healthcare and Life Sciences Podcast
Emerj Technology Research
The AI in Healthcare and Life Sciences is for non-technical leaders interested in where AI is creating an impact for patients, for business workflows, and for the bottom line.
Global Fortune 500 healthcare and life sciences leaders join Emerj AI Research team (and CEO Daniel Faggella) to share where they're seeing AI impact today, as well as best-practices for AI adoption and ROI measurement in healthcare and pharma.
Visit our advertising page to learn more about reaching our executive audience of AI adopters in the world's largest banking and insurance firms: https://emerj.com/advertise
Global Fortune 500 healthcare and life sciences leaders join Emerj AI Research team (and CEO Daniel Faggella) to share where they're seeing AI impact today, as well as best-practices for AI adoption and ROI measurement in healthcare and pharma.
Visit our advertising page to learn more about reaching our executive audience of AI adopters in the world's largest banking and insurance firms: https://emerj.com/advertise
Episodes
Mentioned books
Apr 4, 2024 • 17min
Generative AI for Healthcare - with Dr. Dan Elton of Mass General Brigham
Dr. Dan Elton, a Data Scientist at Mass General Brigham, discusses the shift from reactive to proactive healthcare using AI. Topics include leveraging radiology data, personalized treatment, risk communication, AI applications in healthcare, limitations of smartwatch data, genetic data sensitivity, and empowering patients with clear risk information.
Mar 7, 2024 • 34min
Adopting Generative AI in Healthcare Organizations - with Prashant Natajaran of H2O.ai
Prashant Natajaran from H2O.ai discusses the impact of generative AI in healthcare. Topics include enthusiastic adoption, future models, private-public sector integration, and AI influence in healthcare organizations.
Feb 22, 2024 • 35min
Reducing Hallucinations and Streamlining Drug Discovery Workflows with Generative AI - with Asif Hasan of Quantiphi
Asif Hasan, Co-founder of Quantiphi, discusses AI's impact on reducing hallucinations in healthcare language models and streamlining drug discovery for rare disorders. They explore how Generative AI is revolutionizing drug discovery processes, addressing cost-effective solutions, and enhancing language models with retrieval mechanisms to improve accuracy and reduce hallucinations in regulated contexts. The conversation also highlights the importance of streamlining AI implementation and having experienced champions in organizations
Feb 15, 2024 • 8min
Introducing the 'AI in Healthcare and Life Sciences' Podcast...
A podcast discussing the impact of AI on healthcare and life sciences workflows, emphasizing generative AI applications and streamlining drug development processes. Highlights the importance of human expertise in AI systems and features insights from industry leaders.
